Update from Prague on the EACPT

The EACPT Executive Committee have met in Prague from 13th - 14th May to plan for

Charles Bridge - Prague

its future activities.

These include:

1. A joint EACPT session with EPHAR in Istanbul, June 26-30th 2016.
2. Our next Focus Meeting to be held in Opatija in Croatia from 6th - 9th October 2016
3. The exciting programme shaping up for the EACPT Prague Congress (24-27 June 2017)
4. Plans for major EACPT Awards due in 2017 (Lifetime Achievement - deadline 31st October, 2016; Scientific Award - deadline 31st January, 2017)
5. Support by the EACPT of the new UEMS Clinical Pharmacology Section
6. Activities of the EACPT Working Groups for Research, Education, Regulation and Young Pharmacologists.

October 6-9th 2016 EACPT Focus Meeting on how to assess medicines ...

The theme of the October 6-9th 2016 EACPT Focus Meeting is “How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment”. 

The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner. 

Abstract deadline: June 15th 2016
Early registration deadline: June 30th 2016

EACPT Prague Congress - 24-27 June 2017

The programme will provide an international scientific and educational forum for discussion of clinical pharmacology and therapeutics, including personalised pharmacotherapy.

Themes will include the latest developments on effectiveness and safety of medicines, clinical pharmacology in clinical practice, pharmacokinetics/systems pharmacology, including in special populations, innovative techniques, eHealth, biomarkers, education, advanced practices in topics such as drug discovery, drug development, biological therapies, global health with a focus on access to safe medicines, new pharmacology and pharmacotherapy, safety in prescribing and updates on personalised medicines, as well as updates on specific therapeutic areas, including cardiovascular disease, infectious disease, nephrology, oncology, neurology and psychiatry.

Members of the EACPT Executive Committee in Prague: Back Row: Matthias Schwab (Germany), Donald Singer (UK), Edoardo Spina (Italy), Tabassome Simon (France), Caroline Samer (Switzerland), Marie Besson (Switzerland), Milan Grundmann (Czech Republic); Front ROw: Simon Maxwell (UK), Dinko Vitezic (Croatia), Janne Backman (Finland), Ylva Böttiger (Sweden), Gerard Rongen (Netherlands).

The 2019 EACPT Congress will be held in Stockholm and the 2021 EACPT Congress in Athens. 

Click here to apply online for EACPT membership. 

Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member. 

There are reduced joining fees for Individual Associate members who are already members of a national or international organisation relevant to clinical pharmacology and therapeutics.

 

Membership benefits include:

• Access to videos of talks from EACPT Meetings
• Discounted registration fees for EACPT meetings
• Online access to the Official EACPT Journal - Clinical Therapeutics
• Access to the EACPT’s worldwide network of Individual Associate Members
• Active involvement in EACPT

The EACPT was founded 24 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Clinical Therapeutics, the Official Journal of EACPT.

New Year plans for the EACPT

We wish all our national society and individual members all the best for the festive season and for 2016.

The New Year will see further major activities for the EACPT. These include:

The next EACPT Focus Meeting will be held from 6th to 9th October, 2016 in partnership with the Croatian Society for Clinical Pharmacology and Therapeutics. The theme of the meeting is “How to Assess Medicines from Research to Clinical Practice".

The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner.

Planning is already well underway for the next biennial EACPT Congress, to be held in Prague from 23^rd – 27^th June in 2017. As part of Congress preparations, the next meeting of the EACPT Executive Committee will be in May in Prague.

Following the launch of a new individual associate membership for the EACPT, further working groups have been launched, complementing the established EACPT Education Working Group.These working groups provide excellent opportunities to become actively involved in the running of the EACPT.

EACPT Working Groups:

• Young Clinical Pharmacologists
• Education
• Ethics
• Regulatory 
• Research  

Click here to apply online for EACPT individual membership. 
 
Anyone from anywhere in the world with a professional interest in clinical pharmacology and therapeutics can now join the EACPT as an Individual Associate member. Membership benefits include:

• Active involvement in the EACPT  
• Access to videos of talks from EACPT Meetings 
• Discounted registration fees for EACPT meetings 
• Online access to the Official EACPT Journal - Clinical Therapeutics
•  Access to the EACPT’s worldwide network of Individual Associate Members

The EACPT was founded 23 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

News on next EACPT Congress in Prague: 23rd - 27th June, 2017

The next EACPT Congress will be held in Prague from 23^rd – 27^th June, 2017.

The Prague EACPT Congress in 2017 will provide an international scientific and educational

Prague: Charles bridge and Vltava river

forum for discussion of clinical pharmacology and personalised pharmacotherapy. Themes will include the latest developments on effectiveness and safety of medicines, clinical pharmacology in clinical practice, innovative techniques, and advanced practices in topics such as drug discovery, drug development, new pharmacology and pharmacotherapy, safety in prescribing and updates on personalised medicines. 

The Congress will bring together a wide range of international delegates, including health professionals, clinical and life scientists, policy makers, professionals from the biotechnology and pharmaceutical communities and others interested in the spectrum from basic to clinical pharmacology and pharmacotherapy, and from drug discovery to regulatory affairs. The Congress will include a dedicated session for Young Pharmacologists. 

The following major EACPT Awards will be presented at the Congress.

The EACPT Lifetime Achievement Award is for outstanding contributions to the national and international benefits of clinical pharmacology for medicine, health care and patient safety.

 The EACPT Scientific Award is for the best scientific paper on a topic relevant to clinical pharmacology and therapeutics published by a European clinical pharmacologist over the period between EACPT congresses, based on nominations by the EACPT Council. Criteria are scientific quality, broader impact in science, and the importance of the work in the context of healthcare delivery.

Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member.

Click here to apply online for EACPT membership.

Membership benefits include:

• Discounted registration fees for EACPT meetings

• Access to videos of talks from EACPT Meetings

• Online access to the Official EACPT Journal - Clinical Therapeutics

• Access to the EACPT’s worldwide network of Individual Associate Members

• Active involvement in EACPT 

The EACPT was founded over 20 years ago and now includes all national organisations for clinical pharmacology in Europe. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

EACPT Focus Meeting on How to Assess Medicines: Opatija, Croatia - 6th - 9th October, 2016

The next EACPT Focus Meeting will be held from 6th to 9th October, 2016 in partnership with the Croatian Society for Clinical Pharmacology and Therapeutics.

The theme of the meeting is “How to Assess Medicines from Research to Clinical Practice".

The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner.

The meeting will include a combination of scientific podium lectures, interactive workshops and guided poster sessions covering three main pillars important for the critical assessment of medicinal products - efficacy, effectiveness, and economics (3E assessment).

There will be a dedicated session for Young Pharmacologists during the meeting. There will be an EACPT Scientific Communication Award for the best presentation by a young scientist. 

We will be guests in the Adriatic coastal town Opatija, Croatia. Opatija lies at the centre of the Kvarner Riviera with the longest tradition of providing quality conference venues in Croatia. Opatija’s very attractive geographic location, lush green scenery and a pleasant climate (45° 20’ north latitude) were some of the main reasons for its origins and the rapid development of its tourism from the end of the 19th century.  The venue – Grand Hotel 4 Opatijska Cvijeta –  is located in the very centre of Opatija and includes four buildings that were named after Opatija’s best-known flowers. The hotel has 223 rooms. The hotel also includes the large Tamaris congress centre, which has 7 multi-functional halls and the latest congress equipment. 

Click here to apply online for EACPT membership.

Anyone from anywhere in the world with a professional interest in clinical pharmacology
and therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:

• Access to videos of talks from EACPT Meetings

• Discounted registration fees for EACPT meetings

• Online access to the Official EACPT Journal - Clinical Therapeutics

• Access to the EACPT’s worldwide network of Individual Associate Members

• Active involvement in EACPT 

The EACPT was founded 23 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Opatija, Croatia

2015 EACPT Scientific Award announced

The 2015 EACPT Scientific Award for Professor Nicholas Bateman

The 2015 EACPT Scientific Award is to be conferred on UK Scientist Professor Nicholas Bateman for work on treating paracetamol overdose. The Award which includes a prize of 2000€ will be presented to Professor Bateman at the 12th EACPT Congress in Madrid on Tuesday 30th June 2015.

Professor Bateman's research, which was published in the international medical journal

Professor Nicholas Bateman

The Lancet, involved a clinical trial comparing a new regimen to treat paracetamol poisoning with the current one (which has been used for over 40 years). It is the first large-scale, properly powered and randomised controlled clinical trial conducted in paracetamol poisoning, a challenging environment for trial work. 

This work shows that it is possible to do trials in a group of patients in the emergency room, and across transfer to the wards, most of whom were intending self-harm. This work also shows that other key trials may be possible in this group of patients and in others with overdose. This work also shows how critical are the skills of clinical pharmacology to the design of good clinical toxicology studies.

Paracetamol poisoning is common worldwide and the current standard treatment is complicated and associated with adverse effects related to concentration. The result of Professor Bateman's trial shows that a shorter, simpler infusion regimen of acetylcysteine can cause a major reduction in adverse effects of this important antidote. 

In combination with new biomarkers, that allow identification of at risk patients, this offers the opportunity to simplify treatment, reduce adverse events and shorten hospital stays. The UK MHRA (Medicines and Healthcare products Regulatory Agency) is establishing a working group to take the results of this work forward.

Professor David Nicholas (Nick) BATEMAN BSc, MD, FRCP, FRCP(E), FBPhS, FBTS, FAACT, FEAPCCT, is Honorary Professor in Clinical Toxicology at the University of Edinburgh. His research interests are in clinical toxicology, poisons information systems, and toxico-epidemiology. He has been awarded the Louis Roche award from the European Association of Poisons Centres and Clinical Toxicologists and the Lilly Prize of the British Pharmacology Society. He has published over 160 original research articles, many reviews, edited The Oxford Desk Reference Toxicology and contributed 35 book chapters.

Professor Bateman qualified in medicine at Guy's Hospital Medical School, London. Trained in Clinical Pharmacology in Southampton, the Royal Postgraduate Medical School (Hammersmith Hospital) London, and Newcastle upon Tyne, UK, where he worked for 20 years. He moved to Edinburgh in 1998 as Consultant Clinical Toxicologist and Director, National Poisons Information Service Edinburgh unit (Scottish Poisons Information Bureau) (1998-2012), Royal Infirmary of Edinburgh. Professor Bateman was Chairman of the Poisons Board (UK Home Office) from 2012-2104 and was formerly member of the MHRA Sub-Committee on Pharmacovigilance; the Advisory Committee on Pesticides (HSE) and Chair Medical and Scientific Sub Committee; Veterinary Products Committee (VMD).

He is a Past-President of the European Association of Poison Centres & Clinical Toxicologists.  He was Editor-in-Chief of Clinical Toxicology 2009-11 and formerly managing editor of the European Journal of Clinical Pharmacology (2002-9) and executive editor of the British Journal of Clinical Pharmacology (1988-94). 

Special Recognition for researcher Dr Eva-Luise Hobl from Austria

The EACPT has also awarded Special Recognition to researcher Dr Eva-Luise Hobl from

Dr Eva-Luise Hobl

Austria for her work showing that the pain-killer morphine reduces the blood-thinning effects of the anti-platelet medicine clopidogrel. 

It had been observed that treatment with morphine may lead to poorer outcome after heart attack. Dr Hobl's work, published in the major US publication the Journal of the American College of Cardiology, showed that morphine reduces the absorption, blood levels and effects of the antiplatelet agent clopidogrel. This important drug-drug interaction could reduce the intended effects of clopidogrel to prevent heart attack and other serious vascular diseases. This work suggests that when morphine use is indicated after heart attack, alternative antiplatelet agents should be used.

Dr Hobl studied Pharmacy at the University of Vienna and obtained her Doctor of Applied Medical Science degree from the Medical University of Vienna. Between 2005 and 2008, she worked as a hospital pharmacist and started her studies at the Medical University of Vienna in 2007, where she is now postdoctoral research associate. Her main research interest is in drug-drug interactions of antiplatelet drugs. For this work, she has already received several awards; particularly noteworthy are the “Samuel A. Levine Young Clinical Investigator Award” from the American Heart Association and the “EPHAR Young Clinical Investigator Award 2014”.

Still time to register for the EACPT Congress in Madrid

Plaza major, Madrid

The 12th biennial Congress of the EACPT is being held in Madrid from 27^th to 30^th June 2015. There is still time to register for the Congress.

Over 500 abstracts have been accepted for presentation as e-posters. 54 oral presentations will be eligible for an award for the best talk.

Listen to podcasts from the latest EACPT Congress in Geneva

2013 EACPT Lifetime Award winner Professor Carlo Patrono on platelets, cardiovascular risk & cancer

Podcasts with speakers at the 2013 EACPT Congress in Geneva
- Patrick Mismetti on clinical drug development of new anticoagulants
- Tabassome Simon discusses Clinical Pharmacology and the FAST-MI Registry
- Tabassome Simon discusses the origins and importance of the FAST-MI Registry
- EACPT Congress keynote lecturer Ziad Mallat discusses developing a clinical research career
- EACPT Congress keynote lecturer Ziad Mallat discusses immunotherapy against vascular disease

Comments from delegates on the 2013 EACPT Congress in Geneva
- Swiss Delegates from Zurich and Basel
- Jelena Vukovic from Serbia & Marija Bosilkovska from Geneva
- George Dugbartey and Sorayeh Moradi
- Sarawut Jindarat from Thailand
- Yukari and Ryuichi Ogawa from Tokyo
- Kristina Münch and Barbara Pfistermeister from Germany
- Lada Leyens from Switzerland

Update from Kiel on the EACPT

The EACPT Executive Committee has been meeting in warm and sunny Kiel in

Altstadt - the old centre of Kiel

Northern Germany over the weekend of 10^th-11^th April, in advance of the 12th biennial Congress of the EACPT, to be held in Madrid from 27^th to 30^th June 2015.

The final programme was discussed for the 2015 EACPT Congress in Madrid. Over 500 abstracts have been accepted for presentation as e-posters and as 54 oral presentations, eligible for an award for the best talk.

EACPT EC Meeting at University in Kiel

The 12th EACPT Congress in 2015 is an unparalleled educational forum where you will learn about the newest developments, innovative techniques, and advanced practices in topics such as drug discovery, drug development, pharmacology and pharmacotherapy.
The Congress gives you the unique opportunity to network with top ranking specialists in pharmacology and pharmacotherapy, from around the world, and learn from the best. Reviews and commentaries from the Congress will be published in the EACPT Official Journal - Clinical Therapeutics.
The Congress will provide excellent formal and informal networking opportunities, supported after the Congress through the new website of the EACPT, due to be launched within the coming month.

There is to be launch of a new Associate Membership category for the EACPT, included within registration for the Madrid June 2015 Congress. Associate Members will have discounts on registration for EACPT Congresses and Focus Meetings, online access to the official EACPT journal Clinical Therapeutics, and many opportunities to become directly involved in networking with fellow clinical pharmacologists from throughout Europe and further afield.

Nominations were discussed for EACPT Awards to be presented at the 12^th EACPT Congress in Madrid. The EACPT Lifetime Award is for significant achievement in clinical pharmacology and therapeutics, both for the benefit of science and also for the benefit and health of the specialty, over a whole working life. The EACPT Scientific Award is awarded for the best scientific paper on a topic relevant to clinical pharmacology published by a European clinical pharmacologist in the two years between EACPT congresses. The EPHAR-EACPT award is by the Federation of European Pharmacology Societies (EPHAR) and the EACPT - a joint initiative to award the best work in translational research in pharmacology. There will be 2 awards of 1,000 € each, that will be given in 2015 to young scientists who have published an outstanding research paper in the past two years.
There were reports on interaction with other professional organisations and societies, including the European Medicines Agency, IUPHAR, the International Union of Pharmacology and EPHAR, the European Federation of Pharmacology Societies. Plans with EPHAR, in addition to the above awards, include a joint session on immunopharmacology during the Madrid Congress in June.
Calls were agreed for future EACPT Focus Meetings, with a deadline 31^st May 2015 for bids for summer 2016 and summer 2017. The 2017 meeting will be held in Prague as a Satellite Meeting of the 2017 EACPT Prague Congress
Bids were discussed in outline for the 2021 EACPT Congress, for which proposals from the Dutch Society for Clinical Pharmacology and the Hellenic Society of Basic and Clinical Pharmacology have been short-listed. The 2017 EACPT Congress will be held in Prague and the 2019 EACPT Congress in Stockholm.
Register for the EACPT Congress in Madrid – 27th-30th June 2015
Clinical Therapeutics -  Official Journal of the EACPT
__________________________________________________________
Listen to podcasts from the latest EACPT Congress in Geneva
2013 EACPT Lifetime Award winner Professor Carlo Patrono on platelets, cardiovascular risk & cancer


Podcasts with speakers at the 2013 EACPT Congress in Geneva
- Patrick Mismetti on clinical drug development of new anticoagulants
- Tabassome Simon discusses Clinical Pharmacology and the FAST-MI Registry
- Tabassome Simon discusses the origins and importance of the FAST-MI Registry
- EACPT Congress keynote lecturer Ziad Mallat discusses developing a clinical research career
- EACPT Congress keynote lecturer Ziad Mallat discusses immunotherapy against vascular disease


Comments from delegates on the 2013 EACPT Congress in Geneva
- Swiss Delegates from Zurich and Basel
- Jelena Vukovic from Serbia & Marija Bosilkovska from Geneva
- George Dugbartey and Sorayeh Moradi
- Sarawut Jindarat from Thailand
- Yukari and Ryuichi Ogawa from Tokyo
- Kristina Münch and Barbara Pfistermeister from Germany
- Lada Leyens from Switzerland